HEMOBIOTECH, INC.·5

Feb 17, 4:41 PM ET

Bollon Arthur 5

5 · HEMOBIOTECH, INC. · Filed Feb 17, 2009

Insider Transaction Report

Form 5
Period: 2009-02-17
Bollon Arthur
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option

    2008-04-23+100,000100,000 total
    Exercise: $1.25Exp: 2013-04-23Common Stock (100,000 underlying)
  • Other

    Common Stock

    2003-04-08$0.00/sh117,000$2341,599,059 total
  • Other

    Common Stock

    2008-11-02$1.25/sh52,778$65,9731,599,059 total
Footnotes (4)
  • [F1]Shares originally reported as beneficially owned by reporting person on Form 3. Reporting person disclaims beneficial ownership and has no pecuniary interest in these 117,000 Shares.
  • [F2]Form 4 filed on November 2, 2008 inadvertently listed vested options as Common Shares.
  • [F3]As reported on Form 4 November 2, 2008 1,768,837 Shares (117,000)see above ( 52,778)see above 1,599,059see above
  • [F4]Options vest 50% immediately upon issuance and the remainder vest over 36 monthly installments.

Documents

1 file
  • 5
    doc1.xmlPrimary

    FORM 5